Progyny Inc (PGNY)

Working capital turnover

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Revenue US$ in thousands 1,165,810 1,091,910 787,727 501,082 344,979
Total current assets US$ in thousands 472,721 640,407 433,856 258,539 190,222
Total current liabilities US$ in thousands 168,627 185,950 159,536 98,824 77,786
Working capital turnover 3.83 2.40 2.87 3.14 3.07

December 31, 2024 calculation

Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $1,165,810K ÷ ($472,721K – $168,627K)
= 3.83

Progyny Inc's working capital turnover has shown fluctuations over the past five years. The ratio increased from 3.07 in December 2020 to 3.14 in December 2021, indicating an efficient management of working capital to generate revenue. However, there was a decrease in the ratio to 2.87 in December 2022, suggesting a potential challenge in efficiently utilizing working capital to support the company's operations.

Furthermore, the working capital turnover ratio declined significantly to 2.40 by December 2023, which may indicate potential inefficiencies in managing the company's working capital during that period. However, there was a notable recovery in the ratio to 3.83 by December 2024, reflecting a possible improvement in working capital management efficiency and the ability to effectively convert working capital into revenue.

Overall, Progyny Inc's working capital turnover ratio has displayed fluctuations, showcasing both strengths and areas for improvement in managing its working capital effectively to drive revenue generation.


Peer comparison

Dec 31, 2024

Company name
Symbol
Working capital turnover
Progyny Inc
PGNY
3.83
DaVita HealthCare Partners Inc
DVA
16.59
Sotera Health Co
SHC
3.21